The startup offers a portable in-vitro diagnostic device that analyzes hematological diseases using just a single drop of blood. This technology enhances diagnostic efficiency by providing precise results quickly, addressing the need for accessible and accurate blood testing.
Funding
$392.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional hematological disease diagnostics often require large blood samples, specialized laboratory equipment, and trained personnel, leading to delays in diagnosis and limited accessibility, particularly in resource-constrained settings. Current methods can be invasive, time-consuming, and costly, hindering timely intervention and effective disease management.
Solution
This startup provides a portable in-vitro diagnostic (IVD) device designed for rapid hematological analysis using a single drop of blood. The device aims to enhance diagnostic efficiency by delivering precise results quickly, enabling timely clinical decision-making. By minimizing the need for extensive laboratory infrastructure and large sample volumes, the technology seeks to improve access to accurate blood testing, especially in point-of-care settings and remote locations. The device's ease of use and portability can streamline diagnostic workflows, reduce turnaround times, and facilitate early detection of hematological disorders.
Target Audience
The primary target audience includes healthcare providers in point-of-care settings, clinics in remote or underserved areas, and research institutions focused on hematological disease diagnostics.
Features
- Point-of-care hematological analysis using a single drop of blood
- Rapid results for timely clinical decision-making
- Portable and easy-to-use device for decentralized testing
- Integrated microfluidic technology for precise sample handling
- Automated data analysis and reporting capabilities